Recent Insider Transactions - C4 Therapeutics (NASDAQ: CCCC)

Company

Name / Role

Date

Type

Price

# Shares

Value

Balance

NASDAQ CCCC C4 Therapeutics

Boyle Scott N / officer: Chief Business Officer

11/07/2024

Sell

$6.04

1,102

$7K

56,567

NASDAQ CCCC C4 Therapeutics

Adams Kendra / officer: Chief Financial Officer

11/07/2024

Sell

$6.04

1,102

$7K

84,439

NASDAQ CCCC C4 Therapeutics

Schick Kelly / officer: Chief People Officer

11/07/2024

Sell

$6.04

1,102

$7K

56,488

NASDAQ CCCC C4 Therapeutics

Siegel Jolie / officer: Chief Legal Officer

11/07/2024

Sell

$6.04

1,102

$7K

56,488

NASDAQ CCCC C4 Therapeutics

Hirsch Andrew / director, officer: President & CEO

11/07/2024

Sell

$6.04

5,550

$34K

221,862

NASDAQ CCCC C4 Therapeutics

Mahaney Paige / officer: Chief Scientific Officer

10/28/2024

Buy

$6.00

345,600

$2.074M

345,600

NASDAQ CCCC C4 Therapeutics

GROGAN DONNA ROY / director

10/01/2024

Buy

$5.56

2,474

$14K

28,942

NASDAQ CCCC C4 Therapeutics

Anderson Kenneth Carl / director

10/01/2024

Buy

$5.56

2,023

$11K

116,694

NASDAQ CCCC C4 Therapeutics

Adams Kendra / officer: Chief Financial Officer

09/18/2024

Sell

$6.38

1,837

$12K

81,791